SynthesisCanadian respiratory journal2025

The Clinical Efficacy and Safety of Nintedanib in the Treatment of Interstitial Lung Disease Among Patients With Systemic Sclerosis: Systematic Review.

Khaled S Al Oweidat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.